Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy. By continuing to use this site without changing your settings you consent to our use of cookies in accordance with our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
Sign In

M&A Insights

​​ ​​
​ ​


Life sciences


Two giant deals dominate an 80% surge in the value of life science transactions this year.




As the UK’s withdrawal from the EU reaches its apparent “endgame”, will it have an impact on global M&A activity?




Germany has become one of the leading markets for PE investment in Europe, what is driving surge?





The U.S. transactions market continues to tower over global M&A activity, but the latter part of the year has seen signs of increasing nervousness.


Further insights​

©2017 Allen & Overy LLP              SITE MAP      LEGAL NOTICES      CONTACT US

  • Add comment (optional)